Verdezyne Inc

CARLSBAD, CA · Founded 2009 · Biotech · Defunct

Bio-based chemicals and polymers produced through synthetic biology and fermentation

Claim this profile

Follows are private to you and power your alerts

Updated · verdezyne.com

Sector
Biotech
Headquarters
CARLSBAD, CA
Founded
2009
Latest Form D
$6M, Nov 2013
Total capital
$25.9M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$25.9M
4 Form D · last Nov 2013
155 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
7
24 pending · first 2016
Rank in peer group#213 of 1449

Capital timeline

20092010201120122013FEDERAL ↑EQUITY ↓Cumulative $25.9M1st Form D$3M2nd Form D$6.3M3rd Form D$10.6M4th Form D$6M
20092010201120122013FEDERAL ↑EQUITY ↓Cumulative $25.9M2nd Form D$6.3M3rd Form D$10.6M

Latest events

  • Private capital raisedForm D · SEC · 4th filing$6M
  • Private capital raisedForm D · SEC · 3rd filing$10.6M
  • Private capital raisedForm D · SEC · 2nd filing$6.3M
  • Private capital raisedForm D · SEC · 1st filing$3M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1449 peers

Line = median

Biotech · Molecule

  • Granted patents#213 · top 15%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Andrew William SenyeiDirectorNamed in SEC Form D filings
  • Brian William ConnExecutive OfficerNamed in SEC Form D filings
  • Chad William WaiteDirectorNamed in SEC Form D filings
  • E William RadanyExecutive Officer, DirectorNamed in SEC Form D filings
  • E. William RadanyExecutive Officer, DirectorNamed in SEC Form D filings
  • Erik William RuttenDirectorNamed in SEC Form D filings
Show all 12 people
  • Meghan William Sharp, Ph.D.DirectorNamed in SEC Form D filings
  • Nancy D OleskiExecutive OfficerNamed in SEC Form D filings
  • Neal William BhadkamkarDirectorNamed in SEC Form D filings
  • Richard D MurphyDirectorNamed in SEC Form D filings
  • Robert William EnglerDirectorNamed in SEC Form D filings
  • Steve D JacksonExecutive OfficerNamed in SEC Form D filings

What it has protected

USPTO · 7 granted of 31
  • PendingBiological Methods For Preparing A Fatty Dicarboxylic AcidUSPTOApplication 15872581
  • PendingBiological Methods For Preparing A Fatty Dicarboxylic AcidUSPTOApplication 15801884
  • PendingBiological Methods For Preparing 3-HYDROXYPROPIONIC AcidUSPTOApplication 15558863
Show all 31 patent records
  • Biological Methods For Preparing A Fatty Dicarboxylic AcidJan 10, 2019 · Application 15872581Pending
  • Biological Methods For Preparing A Fatty Dicarboxylic AcidSep 13, 2018 · Application 15801884Pending
  • Biological Methods For Preparing 3-HYDROXYPROPIONIC AcidMay 31, 2018 · Application 15558863Pending
  • Biological Methods For Preparing A Fatty Dicarboxylic AcidMay 1, 2018 · US 9,957,512Granted
  • Biological Methods For Preparing A Fatty Dicarboxylic AcidApr 10, 2018 · US 9,938,544Granted
  • Biological Methods For Preparing A Fatty Dicarboxylic AcidMar 6, 2018 · US 9,909,151Granted
  • Biological Methods For Preparing A Fatty Dicarboxylic AcidDec 26, 2017 · US 9,850,493Granted
  • Biological Methods For Preparing A Fatty Dicarboxylic AcidSep 19, 2017 · US 9,765,346Granted
  • Purification Of Polycarboxylic AcidsDec 13, 2016 · US 9,517,996Granted
  • Biological Methods For Preparing Adipic AcidSep 6, 2016 · US 9,434,966Granted
  • Biological Methods For Preparing Adipic AcidMar 26, 2015 · Application 14347314Pending
  • Biological Methods For Preparing TerpenesApplication 62532297Pending
  • Purification Of Polycarboxylic AcidsApplication PCTUS2015035634Pending
  • Biological Methods For Preparing 3-HYDROXYPROPIONIC AcidApplication 62136350Pending
  • Purification Of Polycarboxylic AcidsApplication 62011500Pending
  • Biological Methods For Modifying Cellular Carbon FluxApplication 62532292Pending
  • Biological Methods For Preparing A Fatty Dicarboxylic AcidApplication PCTUS2013076739Pending
  • Biological Methods For Preparing A Fatty Dicarboxylic AcidApplication PCTUS2013076664Pending
  • Biological Methods For Preparing A Fatty Dicarboxylic AcidApplication 61739656Pending
  • Biological Methods For Preparing A Fatty Dicarboxylic AcidApplication 61739661Pending
  • Biological Methods For Preparing Adipic AcidApplication PCTUS2012056562Pending
  • Biological Methods For Preparing A Fatty Dicarboxylic AcidApplication PCTUS2012045615Pending
  • Biological Methods For Preparing A Fatty Dicarboxylic AcidApplication PCTUS2012045622Pending
  • Engineered Microorganisms With Enhanced Fermentation AcitivityApplication PCTUS2012020982Pending
  • Biological Methods For Preparing Adipic AcidApplication PCTUS2012020230Pending
  • Combinatorial Methods For Optimizing Engineered Microorganism FunctionApplication PCTUS2010042359Pending
  • Engineered Microorganisms With Enhanced Fermentation ActivityApplication PCTUS2010041618Pending
  • Engineered Microorganisms With Enhanced Fermentation ActivityApplication PCTUS2010041607Pending
  • Biological Methods For Preparing Adipic AcidApplication PCTUS2010040837Pending
  • Biological Methods For Preparing 3-HYDROXYPROPIONIC AcidApplication PCTUS2016023243Pending
  • Aglycosylated Therapeutic Antibodies And Therapeutic Antibody-encoding Nucleotide SequencesApplication PCTUS2008085568Pending
  • Immunitas TherapeuticsSimilar federal contract value in Biotech · null in contracts
  • Therini BioSimilar federal contract value in Biotech · null in contracts
  • EnteroBiotix LTDSimilar federal contract value in Biotech · null in contracts
  • New Culture Inc.Similar federal contract value in Biotech · null in contracts
  • Rapalogix Health, Inc.Similar federal contract value in Biotech · null in contracts
  • GRI BIO OPERATIONS, INC.Similar federal contract value in Biotech · null in contracts

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .